Moving the Goal Posts: Case Study of FDA Approval of Aducanumab to Treat Alzheimer Disease
April 19, 2022
12:30 PM - 1:20 PM
Please join us for our next Pharmacy Resident Seminar presentation on Tuesday, April 19, 2022, presented by UIC College of Pharmacy PGY2 Drug Information Pharmacy Resident, Honey Joseph, PharmD.
Type of Activity: Knowledge Target Audience: Pharmacists
Time: Tuesday, April 19, 2022, 12:30 pm - 1:20 pm
Fees: There is no charge for attending this activity
Location: Chicago, Room 134-1 and via Zoom
Zoom Meeting Information:
Meeting link: https://go.uic.edu/residentseminar2021-2022
Meeting number: 871 4292 0130
Password: 3Rx8KyKR
Or
Join by phone: 1-312-626-6799 (Chicago)
Meeting ID: 871 4292 0130
Passcode: 25699265
Learning Objectives :
At the completion of this activity, the participant will be able to:
- Describe the clinical evidence and safety profile of aducanumab for the treatment of Alzheimer disease
- Discuss the controversy surrounding the US Food and Drug Administration's approval of aducanumab
- Identify clinical and regulatory implications of the approval of aducanumab
Disclosure: The speakers, planning committee members, and reviewers who contributed to this activity have no relevant conflicts of interest to disclose. Mentor, Dr. Spencer has no relevant financial conflicts of interest to disclose.
Date posted
Feb 25, 2022
Date updated
Feb 25, 2022
Speakers
